| Document Date: 2011-07-26 17:54:24
Open Document File Size: 116,66 KBShare Result on Facebook
City Hanoi / Antalya / / Company H5 Reference Laboratory / / Country Thailand / Turkey / / Event FDA Phase / / Facility Blood Institute / Stringent hospital / If laboratory / / IndustryTerm aspirin containing products / therapy for A(H5N1) disease / transportation / treatment of A(H5N1) disease / treatment of other respiratory viral diseases / / MedicalCondition gastric stasis / suspected adrenal insufficiency / A(H5N1) virus infections / dysfunction / human infection / Infectious / human seasonal influenza / viral diseases / particularly acute respiratory distress syndrome / encephalopathy / septic shock / avian influenza / respiratory viral infections / community-acquired pneumonia / illness / infections / influenza / sepsis / A(H5N1) virus human infection / Hypotension / adrenal insufficiency / acute lung injury / pneumonia / necrosis / Human H5N1 Infections / Respiratory failure / disease / arthralgia / SARS / A(H5N1) virus infection / human infections / progressive disease / Reye Syndrome / pulmonary medicine / fever / infectious aerosols / superinfection / opportunistic infection / diseases / infectious diseases / infection / / MedicalTreatment immunization / Antibiotics / IPPV / Immunotherapy / Oxygen therapy / mechanical ventilation / antiviral therapy / immunosuppression / resuscitation / drug therapies / positive pressure ventilation / chemoprophylaxis / / Organization World Health Organization / Salicylates Avoid administration / / Person Duc Hien / / Position MP / General / / Product methylprednisolone / Nokia N95 Smartphone / ampicillin / etoposide / azithromycin / ibuprofen / epinephrine / cefotaxime / hydrocortisone / ceftriaxone / RSV1 / / ProvinceOrState ARDS / / Technology antibodies / Chemotherapy / / URL http /
SocialTag |
Microsoft Word - Clinical Management H5N1_15August2007 _PA changes accpt_Acheck.doc